Trinity Biotech plc Total Non Current Liabilities 2011-2026 | TRIB

Annual Total Non Current Liabilities Trinity Biotech plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
106 M	68.3 M	76.9 M	-	106 M	107 M	90 M	106 M	116 M	130 M	23.8 M	22.5 M	15 M	6.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
130 M	6.9 M	74.9 M

Quarterly Total Non Current Liabilities Trinity Biotech plc

2024-Q4	2024-Q2	2023-Q4	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
106 M	98 M	68.3 M	-	-	-	-	18.7 M	-	-	-	106 M	-	-	-	107 M	-	-	-	90 M	-	107 M	107 M	107 M	-	-	-	116 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
116 M	18.7 M	93.6 M

Total Non Current Liabilities of other stocks in the Diagnostics research industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	23.7 M	-	-6.23 %	$ 30.6 M	Germany
Co-Diagnostics CODX	574 K	$ 1.29	-21.17 %	$ 1.72 M	USA
Agilent Technologies A	3.29 B	$ 111.7	-1.36 %	$ 34 B	USA
Castle Biosciences CSTL	2.76 M	$ 19.13	1.32 %	$ 555 M	USA
Akumin AKU	527 M	-	-17.87 %	$ 25.9 M	Canada
Fulgent Genetics FLGT	2.26 M	$ 15.7	-3.03 %	$ 475 M	USA
Aspira Women's Health AWH	3.49 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	134 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	11.3 M	-	-13.05 %	$ 7.29 M	USA
Illumina ILMN	2.04 B	$ 142.54	-0.49 %	$ 22.7 B	USA
Oxford Immunotec Global PLC OXFD	7.74 M	-	-	$ 562 M	Britain
Interpace Biosciences IDXG	10 M	$ 1.76	-2.22 %	$ 7.79 M	USA
CareDx, Inc CDNA	17.9 M	$ 19.97	-2.54 %	$ 1.06 B	USA
Chembio Diagnostics CEMI	24.8 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	16 K	-	-	$ 9.42 M	Israel
Lantheus Holdings LNTH	225 M	$ 93.91	-2.86 %	$ 6.34 B	USA
HTG Molecular Diagnostics HTGM	4.1 M	-	-20.0 %	$ 1.06 M	USA
Medpace Holdings MEDP	73.8 M	$ 415.27	-0.93 %	$ 12 B	USA
Global Cord Blood Corporation CO	2.53 B	-	-	$ 399 M	China
Mettler-Toledo International MTD	1.61 B	$ 1 031.64	-0.99 %	$ 21.3 B	Schweiz
Fluidigm Corporation FLDM	131 M	-	1.08 %	$ 308 M	USA
Myriad Genetics MYGN	107 M	$ 3.58	-1.1 %	$ 332 M	USA
Genetic Technologies Limited GENE	559 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	48.5 M	-	0.12 %	$ 80.1 M	China
NeoGenomics NEO	435 M	$ 8.24	-1.44 %	$ 1.06 B	USA
DermTech DMTK	865 K	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	39.6 M	$ 18.62	-1.64 %	$ 417 M	USA
Charles River Laboratories International CRL	2.35 B	$ 150.85	-5.3 %	$ 7.48 B	USA
Natera NTRA	124 M	$ 186.36	-5.36 %	$ 18.3 B	USA
PRA Health Sciences, Inc. PRAH	1.43 B	-	-	$ 10.7 B	USA
Enzo Biochem ENZ	4.6 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	981 M	-	-	$ 19.8 B	USA
Koninklijke Philips N.V. PHG	8.45 B	$ 25.23	-1.06 %	$ 23.9 B	Niderland
Guardant Health GH	91.4 M	$ 94.92	-3.79 %	$ 11.9 B	USA
Personalis PSNL	639 K	$ 6.36	-5.22 %	$ 568 M	USA
Heska Corporation HSKA	57.9 M	-	-	$ 1.31 B	USA
ICON Public Limited Company ICLR	461 M	$ 116.38	-0.61 %	$ 9.6 B	Irlanda
Senseonics Holdings SENS	163 M	$ 5.77	-0.86 %	$ 241 M	USA
Soleno Therapeutics SLNO	10.8 M	$ 53.01	0.04 %	$ 2.69 B	USA
QIAGEN N.V. QGEN	1.99 B	-	-	$ 10.6 B	Niderland
Biomerica BMRA	1.57 M	$ 2.34	-2.9 %	$ 5.38 M	USA
Laboratory Corporation of America Holdings LH	7.82 B	$ 250.4	-1.43 %	$ 20.8 B	USA
Thermo Fisher Scientific TMO	22.5 B	$ 438.34	-2.2 %	$ 165 B	USA
Celcuity CELC	69.2 K	$ 137.68	2.2 %	$ 6.44 B	USA
Motus GI Holdings MOTS	2.16 M	-	-34.28 %	$ 263 K	Israel
Twist Bioscience Corporation TWST	4.56 M	$ 49.17	-7.14 %	$ 2.94 B	USA
Neogen Corporation NEOG	19.6 M	$ 8.19	-2.85 %	$ 1.78 B	USA
Quest Diagnostics Incorporated DGX	5.17 B	$ 186.61	-0.71 %	$ 20.7 B	USA
Invitae Corporation NVTA	320 M	-	-	$ 21.2 M	USA